<?xml version='1.0' encoding='utf8'?>
<text id="AMALGUM_interview_discusses" title="part2_Wikinews discusses H1N1 with the WHO" shortTitle="discusses" type="interview" dateCollected="2019-11-05" dateCreated="2010-01-29" dateModified="2019-09-12" sourceURL="https://en.wikinews.org/wiki/Wikinews_discusses_H1N1_with_the_WHO" speakerList="#KM, #MM" speakerCount="2">
<p>
<s type="decl">
Supportive	JJ	supportive
care	NN	care
at	IN	at
home	NN	home
with	IN	with
plenty	NN	plenty
of	IN	of
rest	NN	rest
,	,	,
drinking	VBG	drink
plenty	NN	plenty
of	IN	of
fluids	NNS	fluid
and	CC	and
using	VBG	use
a	DT	a
pain	NN	pain
reliever	NN	reliever
for	IN	for
aches	NNS	ach
and	CC	and
pains	NNS	pain
is	VBZ	be
adequate	JJ	adequate
for	IN	for
recovery	NN	recovery
in	IN	in
most	JJS	most
cases	NNS	case
.	.	.
</s>
<s type="sub">
A	DT	a
non-	JJ	non-
<ref target="https://en.wikipedia.org/wiki/aspirin">
aspirin	NN	aspirin
</ref>
pain	NN	pain
reliever	NN	reliever
should	MD	should
be	VB	be
used	VBN	use
for	IN	for
children	NNS	child
or	CC	or
adolescents	NNS	adolescent
under	IN	under
age	NN	age
18	CD	18
.	.	.
</s>
</p>
<p>
<s type="sub">
The	DT	the
public	NN	public
should	MD	should
be	VB	be
made	VBN	make
aware	JJ	aware
that	IN	that
there	EX	there
are	VBP	be
specific	JJ	specific
groups	NNS	group
of	IN	of
people	NNS	person
who	WP	who
appear	VBP	appear
to	TO	to
be	VB	be
at	IN	at
higher	JJR	high
risk	NN	risk
of	IN	of
more	RBR	more
complicated	JJ	complicated
or	CC	or
severe	JJ	severe
illness	NN	illness
which	WDT	which
include	VBP	include
:	:	:
</s>
</p>
<list type="unordered">
<item>
<s type="frag">
pregnant	JJ	pregnant
women	NNS	woman
;	:	;
</s>
</item>
<item>
<s type="frag">
infants	NNS	infant
,	,	,
and	CC	and
young	JJ	young
children	NNS	child
particularly	RB	particularly
under	IN	under
age	NN	age
2	CD	2
;	:	;
</s>
</item>
<item>
<s type="frag">
people	NNS	person
of	IN	of
any	DT	any
age	NN	age
with	IN	with
certain	JJ	certain
chronic	JJ	chronic
health	NN	health
conditions	NNS	condition
(	-LRB-	(
including	VBG	include
<ref target="https://en.wikipedia.org/wiki/asthma">
asthma	NN	asthma
</ref>
or	CC	or
<ref target="https://en.wikipedia.org/wiki/lung%20disease">
lung	NN	lung
disease	NN	disease
</ref>
,	,	,
<ref target="https://en.wikipedia.org/wiki/heart%20disease">
heart	NN	heart
disease	NN	disease
</ref>
,	,	,
<ref target="https://en.wikipedia.org/wiki/diabetes">
diabetes	NN	diabet
</ref>
,	,	,
kidney	NN	kidney
disease	NN	disease
or	CC	or
some	DT	some
neurological	JJ	neurological
conditions	NNS	condition
)	-RRB-	)
;	:	;
</s>
</item>
<item>
<s type="frag">
people	NNS	person
with	IN	with
severely	RB	severely
compromised	VBN	compromise
immune	JJ	immune
systems	NNS	system
.	.	.
</s>
</item>
</list>
<p>
<s type="decl">
Currently	RB	currently
,	,	,
people	NNS	person
age	NN	age
65	CD	65
or	CC	or
older	JJR	old
are	VBP	be
the	DT	the
least	RBS	least
likely	JJ	likely
to	TO	to
be	VB	be
infected	VBN	infect
with	IN	with
the	DT	the
pandemic	JJ	pandemic
influenza	NN	influenza
,	,	,
but	CC	but
those	DT	this
who	WP	who
do	VBP	do
get	VB	get
sick	JJ	sick
are	VBP	be
also	RB	also
at	IN	at
high	JJ	high
risk	NN	risk
of	IN	of
developing	VBG	develop
serious	JJ	serious
complications	NNS	complication
,	,	,
just	RB	just
as	IN	as
they	PRP	they
are	VBP	be
from	IN	from
seasonal	JJ	seasonal
flu	NN	flu
.	.	.
</s>
</p>
<sp who="#MM">
<p>
<s type="q">
<hi rend="bold">
Is	VBZ	be
it	PRP	it
known	VBN	know
when	WRB	when
the	DT	the
virus	NN	virus
will	MD	will
become	VB	become
less	RBR	less
virulent	JJ	virulent
and	CC	and
cease	VB	cease
becoming	VBG	become
a	DT	a
major	JJ	major
threat	NN	threat
to	IN	to
health	NN	health
and	CC	and
of	IN	of
so	RB	so
when	WRB	when
?	.	?
</hi>
</s>
</p>
</sp>
<sp who="#KM">
<p>
<s type="decl">
It	PRP	it
is	VBZ	be
impossible	JJ	impossible
to	TO	to
predict	VB	predict
when	WRB	when
the	DT	the
pandemic	NN	pandemic
H1N1	NNP	H1N1
virus	NN	virus
will	MD	will
become	VB	become
less	RBR	less
virulent	JJ	virulent
.	.	.
</s>
</p>
</sp>
<figure>
<caption>
<s type="frag">
Diagram	NN	diagram
showing	VBG	show
antigenic	JJ	antigenic
shift	NN	shift
.	.	.
</s>
</caption>
</figure>
<sp who="#MM">
<p>
<s type="q">
<hi rend="bold">
Is	VBZ	be
there	EX	there
a	DT	a
significant	JJ	significant
risk	NN	risk
of	IN	of
H1N1	NN	H1N1
mutating	VBG	mutate
and	CC	and
becoming	VBG	become
more	RBR	more
deadly	JJ	deadly
?	.	?
</hi>
</s>
</p>
</sp>
<sp who="#KM">
<p>
<s type="decl">
Influenza	NN	influenza
viruses	NNS	virus
constantly	RB	constantly
change	VBP	change
through	IN	through
a	DT	a
process	NN	process
called	VBN	call
<ref target="https://en.wikipedia.org/wiki/antigenic%20drift">
antigenic	JJ	antigenic
drift	NN	drift
</ref>
.	.	.
</s>
<s type="decl">
All	DT	all
influenza	NN	influenza
viruses	NNS	virus
undergo	VBP	undergo
this	DT	this
process	NN	process
but	CC	but
there	EX	there
is	VBZ	be
no	DT	no
way	NN	way
to	TO	to
predict	VB	predict
if	IN	if
,	,	,
when	WRB	when
and	CC	and
how	WRB	how
the	DT	the
pandemic	NN	pandemic
H1N1	NNP	H1N1
virus	NN	virus
will	MD	will
shift	VB	shift
.	.	.
</s>
</p>
</sp>
<sp who="#MM">
<p>
<hi rend="bold">
<s type="wh">
Are	VBP	be
the	DT	the
current	JJ	current
anti-flu	JJ	anti-flu
vaccines	NNS	vaccine
effective	JJ	effective
and	CC	and
how	WRB	how
sufficient	JJ	sufficient
is	VBZ	be
the	DT	the
current	JJ	current
supply	NN	supply
?	.	?
</s>
<s type="wh">
Can	MD	can
you	PRP	you
explain	VB	explain
how	WRB	how
these	DT	this
anti-virus	JJ	anti-virus
vaccine	NN	vaccine
work	NN	work
and	CC	and
any	DT	any
possible	JJ	possible
side	NN	side
effects	NNS	effect
?	.	?
</s>
</hi>
</p>
</sp>
<sp who="#KM">
<p>
<s type="decl">
The	DT	the
current	JJ	current
H1N1	NNP	H1N1
vaccines	NNS	vaccine
are	VBP	be
effective	JJ	effective
and	CC	and
supply	NN	supply
is	VBZ	be
sufficient	JJ	sufficient
.	.	.
</s>
<s type="decl">
The	DT	the
safety	NN	safety
profile	NN	profile
of	IN	of
H1N1	NNP	H1N1
vaccines	NNS	vaccine
is	VBZ	be
very	RB	very
good	JJ	good
.	.	.
</s>
<s type="decl">
Outcomes	NNS	outcome
of	IN	of
studies	NNS	study
completed	VBN	complete
to	IN	to
date	NN	date
indicate	VBP	indicate
that	IN	that
pandemic	NN	pandemic
vaccines	NNS	vaccine
have	VBP	have
a	DT	a
similar	JJ	similar
safety	NN	safety
record	NN	record
as	IN	as
seasonal	JJ	seasonal
influenza	NN	influenza
vaccines	NNS	vaccine
.	.	.
</s>
<s type="decl">
Pandemic	JJ	Pandemic
influenza	NN	influenza
vaccines	NNS	vaccine
underwent	VBD	undergo
the	DT	the
same	JJ	same
production	NN	production
and	CC	and
testing	NN	testing
methods	NNS	method
as	IN	as
seasonal	JJ	seasonal
vaccines	NNS	vaccine
.	.	.
</s>
</p>
</sp>
<p>
<s type="decl">
The	DT	the
safety	NN	safety
tracking	NN	tracking
of	IN	of
the	DT	the
vaccine	NN	vaccine
for	IN	for
adverse	JJ	adverse
events	NNS	event
after	IN	after
its	PRP$	its
distribution	NN	distribution
and	CC	and
use	NN	use
worldwide	RB	worldwide
has	VBZ	have
likely	RB	likely
been	VBN	be
the	DT	the
most	RBS	most
thorough	JJ	thorough
and	CC	and
sensitive	JJ	sensitive
in	IN	in
history	NN	history
.	.	.
</s>
</p>
<p>
<s type="decl">
Influenza	NN	influenza
vaccines	NNS	vaccine
cause	VBP	cause
antibodies	NNS	antibody
to	TO	to
develop	VB	develop
in	IN	in
the	DT	the
body	NN	body
.	.	.
</s>
<s type="decl">
These	DT	this
antibodies	NNS	antibody
provide	VBP	provide
protection	NN	protection
against	IN	against
infection	NN	infection
with	IN	with
the	DT	the
viruses	NNS	virus
that	WDT	that
are	VBP	be
in	IN	in
the	DT	the
vaccine	NN	vaccine
.	.	.
</s>
</p>
<p>
<s type="decl">
Possible	JJ	Possible
side	NN	side
effects	NNS	effect
can	MD	can
depend	VB	depend
on	IN	on
the	DT	the
type	NN	type
of	IN	of
vaccine	NN	vaccine
,	,	,
how	WRB	how
it	PRP	it
is	VBZ	be
administered	VBN	administer
and	CC	and
the	DT	the
age	NN	age
of	IN	of
the	DT	the
recipient	NN	recipient
.	.	.
</s>
<s type="decl">
There	EX	there
are	VBP	be
two	CD	2
main	JJ	main
types	NNS	type
of	IN	of
vaccines	NNS	vaccine
:	:	:
one	CD	one
is	VBZ	be
manufactured	VBN	manufacture
with	IN	with
inactivated	VBN	inactivate
viruses	NNS	virus
,	,	,
the	DT	the
other	JJ	other
uses	VBZ	use
live	JJ	live
viruses	NNS	virus
.	.	.
</s>
<s type="decl">
Inactivated	VBN	inactivate
vaccines	NNS	vaccine
,	,	,
administered	VBN	administer
by	IN	by
injection	NN	injection
,	,	,
commonly	RB	commonly
cause	VBP	cause
local	JJ	local
reactions	NNS	reaction
such	JJ	such
as	IN	as
soreness	NN	soreness
,	,	,
swelling	NN	swelling
and	CC	and
redness	NN	redness
at	IN	at
the	DT	the
injection	NN	injection
site	NN	site
,	,	,
and	CC	and
less	RBR	less
often	RB	often
can	MD	can
cause	VB	cause
fever	NN	fever
,	,	,
muscle-	NN	muscle-
or	CC	or
joint-	NN	joint-
aches	NNS	ach
or	CC	or
headache	NN	headache
.	.	.
</s>
<s type="decl">
These	DT	this
symptoms	NNS	symptom
are	VBP	be
generally	RB	generally
mild	JJ	mild
,	,	,
do	VBP	do
not	RB	not
need	VB	need
medical	JJ	medical
attention	NN	attention
,	,	,
and	CC	and
last	JJ	last
1	CD	1
to	IN	to
2	CD	2
days	NNS	day
.	.	.
</s>
<s type="decl">
Fever	NN	Fever
,	,	,
aches	NNS	ach
and	CC	and
headaches	NNS	headache
can	MD	can
occur	VB	occur
more	RBR	more
frequently	RB	frequently
in	IN	in
children	NNS	child
compared	VBN	compare
to	IN	to
elderly	JJ	elderly
people	NNS	person
.	.	.
</s>
</p>
</text>